ProSci specializes in the production of affinity-purified polyclonal and monoclonal antibodies to novel targets in the fields such as apoptosis, HIV, infectious disease, immunology, immune checkpoint, signal transduction, cancer and neurobiology. To date, ProSci has a primary antibody catalog of over 20,000 antibodies. Other catalog items include blocking peptides, recombinant proteins, tissue and cell line slides and lysates.